Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Nvidia Options Price in $280 Billion Earnings Swing 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Trump Buys SpaceX Shares After Record IPO 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Tesla Raises Cybertruck Prices by $5,000 in US 
Add as a preferred source on Google
WALTHAM, Mass., April 19, 2018 -- TESARO, Inc. (NASDAQ:TSRO) will announce first-quarter 2018 financial results on Thursday, May 3, 2018, after the close of the U.S. financial markets. TESARO’s senior management team will host a conference call and live audio webcast at 4:15 p.m. ET on May 3, 2018 to discuss the Company’s operating results for the quarter in greater detail, as well as the status of its development programs.
This quarterly earnings call will be available via phone and webcast. The conference call dial-in information is listed below. To access the webcast, please log on to the TESARO website at www.tesarobio.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.
******************CONFERENCE CALL & WEBCAST INFORMATION******************
TESARO will host a conference call and live audio webcast to discuss its first-quarter financial results.
WHEN: Thursday, May 3, 2018 at 4:15 p.m. ET
LIVE DOMESTIC & CANADA CALL-IN: (877) 853-5334
LIVE INTERNATIONAL CALL-IN: (970) 315-0307
THIS CALL WILL ALSO BE BROADCAST LIVE, LISTEN ONLY, VIA THE WEB AT: www.tesarobio.com
A replay will be available for 30 days at www.tesarobio.com.
**********************************************************************************
About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
Investor/Media Contacts:
Jennifer Davis
Vice President, Corporate Communications and Investor Relations
+1.781.325.1116 or [email protected]
Kate Rausch
Associate Director, Investor Relations
+1.781.257.2505 or [email protected]
